von Willebrand factor: biological function and molecular defects.
The human von Willebrand factor (vWF) plays a pivotal role in the mechanisms of blood clotting and platelet thrombus formation; it also binds and stabilizes factor VIII procoagulant protein. The biological functions of vWF are dependent on distinct molecular domains responsible for the specificity and affinity for ligands. The multimeric structure of vWF provides an array of binding sites that allow multivalent interactions, thus supporting the formation of stable platelet aggregates at the site of vascular injury, particularly under flow conditions characterized by high shear stress. Quantitative and qualitative abnormalities of vWF cause the most common congenital bleeding disorder in humans, the von Willebrand disease (vWD). This review will provide an update on the recent advances toward the elucidation of structure-function relationships and the detection of molecular defects leading to vWD and will highlight the revised classification of vWD.
Perutelli
P
P
Hematology and Oncology Department, G. Gaslini Children's Hospital, Genova, Italy.
Biglino
P
P
Mori
P G
PG
D006493:Heparin / Q000378:metabolism; D006801:Humans; D019038:Platelet Glycoprotein GPIb-IX Complex / Q000378:metabolism; D014842:von Willebrand Diseases / Q000175:diagnosis / Q000628:therapy; D014841:von Willebrand Factor / Q000235:genetics / Q000502:physiology*
D019038:Platelet Glycoprotein GPIb-IX Complex; D014841:von Willebrand Factor; D006493:Heparin